Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

BACKGROUND: The purpose of this analysis was to compare health care costs and utilization among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting muscarinic antagonist (LAMA); LABA AND LAMA; or LABA, LAMA, AND inhaled corticosteroid (ICS) prescription claims. METHODS: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozma, Chris M, Paris, Andrew L, Plauschinat, Craig A, Slaton, Terra, Mackowiak, John I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314579/
https://www.ncbi.nlm.nih.gov/pubmed/22192866
http://dx.doi.org/10.1186/1471-2466-11-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314579/
https://www.ncbi.nlm.nih.gov/pubmed/22192866
http://dx.doi.org/10.1186/1471-2466-11-61

Ejemplares similares